References
- Mitsumoto H. Classification and clinical features of amyotrophic lateral sclerosis. In: Mitsumoto H, Norris FH, eds. Amyotrophic lateral sclerosis: a comprehensive guide to management. New York: Demos, 1994: 1–19
- Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology 1996; 47(4 Suppl 2): S71–81
- Klein LM, Forshew DA. The economic impact of ALS. Neurology 1996; 47(4 Suppl 2): S126–9
- Behnia M, Kelly JJ. Role of electromyography in amyotrophic lateral sclerosis. Muscle Nerve 1991; 14(12): 1236–41
- Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 1994: 124 Suppl: 96–107
- Belsh JM. Differential diagnosis of ALS. Part I. Non-motor neuron diseases and adult-onset spinal muscular atrophies. In: Belsh JM, Schiffman PL, eds. Amyotrophic lateral sclerosis: diagnosis and management for the clinician. Armonk, NY: Futura, 1996: 85–129
- Tandan R. Differential diagnosis of ALS. Part II. ALS-like syndromes and ALS variants. In: Belsh, Schiffman, eds, 6 pp 131–61
- Bensimon G, Lacomblez L, Meininger V, for the ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330(9): 585–91
- Lacomblez L, Bensimon G, Leigh PN, et al, for the Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347(9013): 1425–31
- Miller RG, Bouchard JP, Duquette P, et al, for the ALS/Riluzole Study Group II. Clinical trials of riluzole in patients with ALS. Neurology 1996: 47(4 Suppl 2): 586–90
- Miller R, Swash M. Therapeutic advances in ALS. Neurology 1996: 47(6 Suppl 4): S217
- Doble A. The pharmacology and mechanism of action of riluzole. Neurology 1996: 47(6 Suppl 4): S233–41
- Wokke J. Riluzole. Lancet 1996; 348 (9030): 795–9
- Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1997; 49(3): 657–9
- Riviere M, Meininger V, Zeisser P, et al. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole. Arch Neurol 1998; 55(4): 526–8
- Mitsumoto H. Riluzole—what is its impact in our treatment and understanding of amyotrophic lateral sclerosis? Ann Pharmacother 1997; 31(6): 779–81
- Mitsumoto H, Olney RK. Drug combination treatment in patients with ALS: current status and future directions. Neurology 1996; 47(4 Suppl 2): S103–7